CDSCO Panel grants Sanofi's Protocol Amendment Proposal for Quadrivalent Meningococcal Conjugate Vaccine Dr. Divya Colin19 March 2023 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Sanofi Healthcare's...
Conduct PMS study for Hepatitis B Vaccine r-DNA : CDSCO Tells Biological E Dr. Divya Colin18 March 2023 6:00 PM ISTNew Delhi: Rejecting the pharmaceutical major Biological E proposal for waiving the post marketing surveillance (PMS) study, the Subject Expert...
GSK declares positive pivotal phase III data for 5-in-1 Meningococcal ABCWY vaccine Ruchika Sharma15 March 2023 5:30 PM ISTLondon: GSK plc has announced positive headline results from the phase III trial (NCT04502693) evaluating the safety, tolerability, and immunogenicity...
Pfizer gets USFDA emergency use nod for Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma15 March 2023 12:15 PM ISTThe Pfizer-BioNTech COVID-19 Vaccines (COMIRNATY) are based on BioNTech's proprietary mRNA technology and were developed by both BioNTech and Pfizer.
Too little sleep blunts immune response and may make vaccination less effective Dr. Kamal Kant Kohli14 March 2023 11:00 AM ISTResearchers have found in a new study that too little sleep blunts immune response and may make vaccination less effective.According to the...
New TB Vaccine Safe,Temperature Stable and provides prompt Immune Response Dr. Kamal Kant Kohli13 March 2023 3:15 AM ISTA clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and...
GSK, Pfizer ready to launch RSV vaccines for older adults in US Ruchika Sharma12 March 2023 2:30 PM ISTRSV is a leading cause of pneumonia in infants and the elderly, and decades of research have finally resulted in the two successful vaccines Pfizer...
Moderna COVID-19 vaccine linked to more delayed cutaneous reactions Dr. Shravani Dali9 March 2023 12:00 PM ISTModerna COVID-19 vaccine linked to more delayed cutaneous reactions suggests a new study published in The Journal of Allergy and Clinical...
USFDA approves intramuscular administration for Merck’s MMRV Family of Vaccines: M-M-RII, VARIVAX, ProQuad Ruchika Sharma7 March 2023 11:22 AM ISTProQuad is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12...
Revise Phase II/III CT protocol of Yellow Fever Vaccine Live: CDSCO Panel Tells Serum Institute of India Dr. Divya Colin4 March 2023 6:00 PM ISTNew Delhi: Reviewing the proposal presented by the vaccine maker Serum Institute of India to conduct Phase II/III clinical trial of Yellow Fever...
Health Ministry gets Porter Prize 2023 for COVID-19 management Kajal Rajput3 March 2023 1:00 PM ISTThe prize recognizes the strategy followed by the Government of India in managing COVID-19, the approach, and involvement of various stakeholders...
Pfizer, BioNTech submit application to USFDA for emergency use nod of Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma2 March 2023 4:15 PM ISTNew York: Pfizer Inc. and BioNTech SE have submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use...
